Mark Iwicki

CEO

Inhibikase Therapeutics, Inc. (IKT)

Board Member

Inhibikase Therapeutics, Inc. (IKT)

CEO

KALA BIO, Inc. (KALA)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Inhibikase Therapeutics, Inc. (IKT)
CEO

Proxy statement

Current
Inhibikase Therapeutics, Inc. (IKT)
Board Member

Proxy statement

Current
KALA BIO, Inc. (KALA)
CEO

Proxy statement

Current
Jade Biosciences, Inc. (JBIO)
Board Member

Proxy statement

Start not stated–2025-04-28
KALA BIO, Inc. (KALA)
Board Member

Proxy statement

Start not stated–2025-12-19
KALA BIO, Inc. (KALA)
CEO

Proxy statement

Start not stated–2025-02-11

Company network

Recorded roles and earnings-call appearances connecting this person to public companies.

KALA

Current role

CEO, Board Member

10 calls Latest call 2022-08-11

View earnings calls

Inhibikase Therapeutics, Inc.

IKT

Current role

CEO, Board Member

Jade Biosciences, Inc.

JBIO

Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Inhibikase Therapeutics, Inc. (IKT)	Chief Executive Officer and Director	$624,208	—	—	$29,429,299	$532,500	—	$30,586,007
2024	KALA BIO, Inc. (KALA)	Former Chief Executive Officer	$709,394	$297,945	$100,100	$377,628	—	$6,120	$1,491,187
2023	KALA BIO, Inc. (KALA)	Former Chief Executive Officer	$709,394	$297,945	$4,615,426	$2,713,852	—	$6,097	$8,342,714
2022	KALA BIO, Inc. (KALA)	Chief Executive Officer	$682,110	$409,266	—	$770,803	—	$6,120	$1,868,299
2021	KALA BIO, Inc. (KALA)	Chief Executive Officer	$643,500	$270,270	$521,360	$1,330,806	—	$6,120	$2,772,056

Recent activity

Earnings-call appearances and filed executive appointments or departures, newest first.

Executive change Resigned: director KALA BIO, Inc. (KALA)
2025-12-29
Executive change Resigned: Class II director KALA BIO, Inc. (KALA)
2025-12-19
Executive change Resigned: Aerovate's board of directors Jade Biosciences, Inc. (JBIO)
2025-04-28
Earnings call KALA BIO, Inc. Q2 FY2022 Earnings Call KALA BIO, Inc. (KALA)
2022-08-11
Earnings call KALA BIO, Inc. Q1 FY2022 Earnings Call KALA BIO, Inc. (KALA)
2022-05-16
Earnings call KALA BIO, Inc. Q4 FY2021 Earnings Call KALA BIO, Inc. (KALA)
2022-03-29
Earnings call KALA BIO, Inc. Q3 FY2021 Earnings Call KALA BIO, Inc. (KALA)
2021-11-15
Earnings call KALA BIO, Inc. Q2 FY2021 Earnings Call KALA BIO, Inc. (KALA)
2021-08-05
Earnings call KALA BIO, Inc. Q1 FY2021 Earnings Call KALA BIO, Inc. (KALA)
2021-05-05
Earnings call KALA BIO, Inc. Q4 FY2020 Earnings Call KALA BIO, Inc. (KALA)
2021-01-07
Earnings call KALA BIO, Inc. Q3 FY2020 Earnings Call KALA BIO, Inc. (KALA)
2020-10-27
Earnings call KALA BIO, Inc. Q2 FY2020 Earnings Call KALA BIO, Inc. (KALA)
2020-08-06

Show 1 earlier activities

Earnings call KALA BIO, Inc. Q1 FY2020 Earnings Call KALA BIO, Inc. (KALA)
2020-05-07